Intrinsiqq
PDS Biotechnology Corporation logo

PDS Biotechnology Corporation Insider Trading

PDSB

Compare
Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Feb 2025.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
Feb 2025
Feb 28, 2025

Get an email when PDSB's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Feb 28, 2025
    Gregory Gene Freitag
    Director · bought 15,060 at $1.66
    25K
    33% of stake
  • Feb 28, 2025
    Stephen C. Glover
    Director · bought 15,061 at $1.66
    25K
    24% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PDSB, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with PDSB

CompareIntrinsic value
BYSIBeyondSpring Inc.
$0.33-24.49%20
RNTXRein Therapeutics Inc.
$0.37+3.58%10
JAGXJaguar Health, Inc.
$0.22-31.50%40
UNCYUnicycive Therapeutics Inc.
$3.35-5.10%10
COCPCocrystal Pharma Inc.
$0.93-4.11%10
SCNXScienture Holdings Inc.
$2.28-6.45%0
ANVSAnnovis Bio, Inc.
$0.71-5.16%10
KTTAPasithea Therapeutics Corp.
$0.48-0.48%40

Held by ETFs

PDSB is in 1 US ETF. The largest of them, with PDSB's weight in each:

Spot a number that looks wrong? Check it in PDSB's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing PDSB

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.